COMMUNIQUÉS West-GlobeNewswire

FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline

08/08/2018 - 20:20

-- Positive vote for both the skin infections and pneumonia indications -- -- FDA decision expected in early October 2018 -- BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today [...]

Tetra Bio-Pharma’s Dr. Chamberland to Announce Health Canada’s Green Light for the Cannabis vs. Fentanyl Trial

08/08/2018 - 20:16

ORLEANS, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that Health Canada has [...]

SPINEWAY : Ordinary and Extraordinary General Shareholders' Meeting of 13 September Access to preparatory documentation

08/08/2018 - 17:46

Press release Ecully, 8 August 2018 Ordinary and Extraordinary General Shareholders' Meeting of 13 September Access to preparatory documentation The shareholders of SPINEWAY are invited to attend the Ordinary and [...]

SPINEWAY : Assemblée Générale mixte du 13 septembre Mise à disposition des documents préparatoires

08/08/2018 - 17:46

Communiqué de presse Ecully, le 8 août 2018 Assemblée Générale mixte du 13 septembre Mise à disposition des documents préparatoires Les actionnaires de la société SPINEWAY sont invités à participer à l'Assemblée [...]

Bavarian Nordic to Host First Half 2018 Results Conference Call

08/08/2018 - 17:31

COPENHAGEN, Denmark - August 8 , 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2018 first half results on Thursday, August 16, 2018. The management of Bavarian Nordic will host a conference call [...]

Yun Yen, MD, PhD and Winson (Sze Chun) Ho, MD Join Lixte Biotechnology’s Board of Directors

08/08/2018 - 17:30

EAST SETAUKET, NY, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced today the appointments of two new members to the Board of Directors of Lixte: Yun Yen, MD, PhD and Winson ( [...]

The Alliance for Regenerative Medicine Releases Q2 2018 Data Report, Highlighting Sector Trends and Metrics

08/08/2018 - 17:18

WASHINGTON, D.C., Aug. 08, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue [...]

Genmab Announces Financial Results for the First Half of 2018

08/08/2018 - 17:02

August 8, 2018; Copenhagen, Denmark; Interim Report for the First Half of 2018 Highlights USD 943 million in net sales of DARZALEX ® (daratumumab), resulting in royalty income of DKK 695 million U.S. FDA approved [...]

Bio-Path Holdings to Announce Second Quarter 2018 Financial Results on August 15, 2018

08/08/2018 - 15:15

HOUSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted [...]

Medecision Launches Aerial UM Connector™ to Drive In-Network Referrals and CMS Reporting Compliance for Government Health Plans and TPAs

08/08/2018 - 15:00

SaaS application connects provider contract and member enrollment details for real-time authorizations and referrals, eliminates costs and delays tied to manual utilization management and universe creation DALLAS, Aug. [...]

BioStem Technologies Inc. Launches Expanded Shareholder Communications Initiative

08/08/2018 - 15:00

Pompano Beach, FL, Aug. 08, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration [...]

NSS Labs Announces Industry’s First SD-WAN Group Test Results

08/08/2018 - 15:00

3 products receive Recommended Rating; 4 products receive Verified Rating; and 2 products receive Caution rating AUSTIN, Texas, Aug. 08, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for [...]

CBT Pharmaceuticals Receives First Australian Ethics Approval to Initiate APOLLO-1 Phase 1/2 Clinical Trial for Hepatocellular and Renal Cell Carcinoma

08/08/2018 - 14:50

APOLLO-1 will combine CBT’s proprietary c-Met inhibitor with anti PD-1 cancer immunotherapies PLEASANTON, Calif. and HANGZHOU, China, Aug. 08, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based [...]

World-Renowned Neurosurgeon, Health and Nutrition Expert, Dr. Joseph Maroon, Joins CV Sciences, Inc. Board of Directors

08/08/2018 - 14:45

LAS VEGAS, Aug. 08, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”) is pleased to announce the appointment of Joseph Maroon, MD, FACS (“Dr. Maroon”), to its Board of [...]

Altasciences’ Chris Perkin Honored as One of 100 Most Inspiring Leaders in the Life Sciences Industry

08/08/2018 - 14:31

LAVAL, Quebec, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Altasciences, a leading North American early phase contract research organization (CRO), is pleased to announce that, for a fourth consecutive year, CEO Chris Perkin has [...]

Chris Perkin d’Altasciences nommé parmi les 100 leaders les plus inspirants de l’industrie des sciences de la vie

08/08/2018 - 14:31

LAVAL, Québec, 08 août 2018 (GLOBE NEWSWIRE) -- Altasciences, l’une des principales organisations de recherche contractuelle en Amérique du Nord spécialisées dans les premières phases de développement de médicaments, a [...]

Marrone Bio Innovations’ Biological Fumigant Offers Superior Pre-Plant Control of Soil-Borne Plant Diseases and Plant Parasitic Nematodes in Agricultural Soils

08/08/2018 - 14:31

Growers or Their Advisors Encouraged to Contact MBI About Participating in Additional Small-Scale Field Evaluations For Fall 2018 DAVIS, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: [...]

Bespoke Extracts Names JOH as Exclusive Broker of Bespoke CBD Products in U.S. Northeast Region

08/08/2018 - 14:30

SUNNY ISLES, Fla., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, today announced that it has named JOH as the [...]

Albireo to Present at Wedbush PacGrow Healthcare Conference

08/08/2018 - 14:30

BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and [...]